These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 30108199)

  • 1. Deciphering Key Pharmacological Pathways of Qingdai Acting on Chronic Myeloid Leukemia Using a Network Pharmacology-Based Strategy.
    Li H; Liu L; Liu C; Zhuang J; Zhou C; Yang J; Gao C; Liu G; Lv Q; Sun C
    Med Sci Monit; 2018 Aug; 24():5668-5688. PubMed ID: 30108199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Systems Biology-Based Approach to Uncovering Molecular Mechanisms Underlying Effects of Traditional Chinese Medicine Qingdai in Chronic Myelogenous Leukemia, Involving Integration of Network Pharmacology and Molecular Docking Technology.
    Zhou C; Liu L; Zhuang J; Wei J; Zhang T; Gao C; Liu C; Li H; Si H; Sun C
    Med Sci Monit; 2018 Jun; 24():4305-4316. PubMed ID: 29934492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deciphering the pharmacological mechanism of the Chinese formula huanglian-jie-du decoction in the treatment of ischemic stroke using a systems biology-based strategy.
    Zhang YQ; Wang SS; Zhu WL; Ma Y; Zhang FB; Liang RX; Xu HY; Yang HJ
    Acta Pharmacol Sin; 2015 Jun; 36(6):724-33. PubMed ID: 25937634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network pharmacology-based identification of key pharmacological pathways of Yin-Huang-Qing-Fei capsule acting on chronic bronchitis.
    Yu G; Zhang Y; Ren W; Dong L; Li J; Geng Y; Zhang Y; Li D; Xu H; Yang H
    Int J Chron Obstruct Pulmon Dis; 2017; 12():85-94. PubMed ID: 28053519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of Procyanidin B2 in the Treatment of Chronic Myeloid Leukemia Based on Integrating Network Pharmacology and Molecular Docking.
    Li HX; Jing YX; Chai YH; Sun XH; He XX; Xue SL; Xi YM; Ma XL
    Anticancer Agents Med Chem; 2023; 23(16):1838-1847. PubMed ID: 37246327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring pharmacological mechanisms of Xueshuan-Xinmai-Ning tablets acting on coronary heart disease based on drug target-disease gene interaction network.
    Mao X; Xu H; Li S; Su J; Li W; Guo Q; Wang P; Guo R; Xiao X; Zhang Y; Yang H
    Phytomedicine; 2019 Feb; 54():159-168. PubMed ID: 30668365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of salidroside in the treatment of chronic myeloid leukemia based on the network pharmacology and molecular docking.
    Chai Y; Chen F; Li Z; Yang P; Zhou Q; Liu W; Xi Y
    Clin Transl Oncol; 2023 Feb; 25(2):384-395. PubMed ID: 36369630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Mechanism of Caulis Spatholobi in the Treatment of Chronic Myeloid Leukemia based on Network Pharmacology and Experimental Verification.
    Wu Y; Lian F; Chen H; Zhang C; Wei L; Tian H
    Curr Comput Aided Drug Des; 2024; 20(1):49-59. PubMed ID: 37073142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network Pharmacology-Based Exploration of Synergistic Mechanism of Guanxin II Formula (II) for Coronary Heart Disease.
    Sheng S; Yang ZX; Xu FQ; Huang Y
    Chin J Integr Med; 2021 Feb; 27(2):106-114. PubMed ID: 32388823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying cancer-related molecular targets of Nandina domestica Thunb. by network pharmacology-based analysis in combination with chemical profiling and molecular docking studies.
    Taha KF; Khalil M; Abubakr MS; Shawky E
    J Ethnopharmacol; 2020 Mar; 249():112413. PubMed ID: 31760157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Main active constituent identification in Guanxinjing capsule, a traditional Chinese medicine, for the treatment of coronary heart disease complicated with depression.
    Zhang YQ; Guo QY; Li QY; Ren WQ; Tang SH; Wang SS; Liang RX; Li DF; Zhang Y; Xu HY; Yang HJ
    Acta Pharmacol Sin; 2018 Jun; 39(6):975-987. PubMed ID: 28858293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network Pharmacology-Based Pharmacological Mechanism of the Chinese Medicine Rhizoma drynariae Against Osteoporosis.
    Gan D; Xu X; Chen D; Feng P; Xu Z
    Med Sci Monit; 2019 Aug; 25():5700-5716. PubMed ID: 31368456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network pharmacology-based strategy to investigate pharmacological mechanisms of Zuojinwan for treatment of gastritis.
    Yu G; Wang W; Wang X; Xu M; Zhang L; Ding L; Guo R; Shi Y
    BMC Complement Altern Med; 2018 Nov; 18(1):292. PubMed ID: 30382864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on mechanism of Tibetan medicine Zuomua Decoction in treatment of hypertension based on network pharmacology and molecular docking technology].
    Ba-Jia G; Yue R; Jing MA; Sang G; Jie-Ren-Qing D; Gong-Yu LI; Ma-Ci-Ren NI; Yan-Ling Z
    Zhongguo Zhong Yao Za Zhi; 2020 Nov; 45(22):5383-5392. PubMed ID: 33350197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network pharmacology-based strategy for predicting active ingredients and potential targets of Yangxinshi tablet for treating heart failure.
    Chen L; Cao Y; Zhang H; Lv D; Zhao Y; Liu Y; Ye G; Chai Y
    J Ethnopharmacol; 2018 Jun; 219():359-368. PubMed ID: 29366769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of Qingdai compound on expression of bcr/abl and JWA in K562 cells].
    Dai HP; Shen Q; Zhou JW; Tang WY; Zhu GR; Xia W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):809-11. PubMed ID: 16277847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of the mechanisms of action of Shenkang in chronic kidney disease: A network pharmacology study and experimental validation.
    Qin T; Wu L; Hua Q; Song Z; Pan Y; Liu T
    J Ethnopharmacol; 2020 Jan; 246():112128. PubMed ID: 31386888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sonic hedgehog signaling regulates Bcr-Abl expression in human chronic myeloid leukemia cells.
    Liao HF; Su YC; Zheng ZY; Jhih Cai C; Hou MH; Chao KS; Chen YJ
    Biomed Pharmacother; 2012 Jul; 66(5):378-83. PubMed ID: 22397755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia.
    Zeng X; Zhao H; Li Y; Fan J; Sun Y; Wang S; Wang Z; Song P; Ju D
    Autophagy; 2015; 11(2):355-72. PubMed ID: 25701353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying potential quality markers of Xin-Su-Ning capsules acting on arrhythmia by integrating UHPLC-LTQ-Orbitrap, ADME prediction and network target analysis.
    Guo R; Zhang X; Su J; Xu H; Zhang Y; Zhang F; Li D; Zhang Y; Xiao X; Ma S; Yang H
    Phytomedicine; 2018 May; 44():117-128. PubMed ID: 29526583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.